Abiomed Inc. (NASDAQ:ABMD)

The valuation multiples exhibit a pattern of high volatility, characterized by a significant peak in 2018 followed by a substantial correction in 2019. While profitability-based multiples have shown signs of recovery since 2020, asset-based and revenue-based multiples have generally trended lower over the analyzed six-year period.

Price to Earnings (P/E) and Price to Operating Profit (P/OP)

Both profitability ratios followed a nearly identical trajectory, peaking in 2018 at 156.41 and 111.65, respectively. A sharp contraction occurred in 2019, with the P/E ratio falling to 45.76 and the P/OP to 52.72. Since 2020, these ratios have trended upward, with the P/E reaching 78.69 and the P/OP reaching 76.33 by March 31, 2022, suggesting a renewed expansion in the premium attributed to earnings and operating performance.

Price to Sales (P/S)

The P/S ratio experienced an extreme expansion in 2018, reaching a peak of 29.55. This was followed by a general downward trend that reached a low of 10.50 in 2020. Despite a temporary increase to 14.96 in 2021, the ratio ended the period at 10.41, indicating a significant long-term contraction in the multiple paid relative to revenue.

Price to Book Value (P/BV)

A sustained downward trend is observed in the P/BV ratio following its 2018 peak of 25.44. The ratio declined steadily to 8.28 in 2020 and reached its lowest point of 7.15 by March 31, 2022. This suggests a progressive reduction in the market's valuation of the stock relative to its equity book value.

A notable divergence is observed in 2022, where P/E and P/OP ratios increased while P/S and P/BV ratios declined. This pattern indicates that the increase in valuation multiples is being driven by improvements in bottom-line profitability rather than by revenue growth or asset accumulation.

The valuation metrics of the entity exhibit significant volatility over the six-year period ending March 31, 2022. The initial years are characterized by extreme price-to-earnings (P/E) multiples, suggesting high investor growth expectations, while later years demonstrate a transition toward more moderated, though still elevated, valuation levels.

Share Price and Earnings Per Share (EPS) Dynamics

The share price experienced a substantial peak in March 2018 at 394.46 US$. Interestingly, the highest EPS of 5.74 US$ was achieved in March 2019, a period during which the share price had already declined to 262.64 US$. This indicates a decoupling of price movement from earnings growth between 2018 and 2019.

Price-to-Earnings (P/E) Ratio Trends

The P/E ratio peaked at 156.41 in March 2018 before undergoing a sharp contraction to 45.76 in 2019 and 43.48 in 2020. This significant reduction suggests a market correction in valuation expectations. From 2021 onward, the multiple trended upward again, rising from 56.24 to 78.69 by March 2022.

Analysis of 2022 Valuation Divergence

In the final reported year, both the share price and EPS declined, with the share price falling to 235.75 US$ and EPS decreasing to 3.00 US$. Because the decline in earnings was proportionally greater than the decline in share price, the P/E ratio expanded to 78.69, reflecting a higher valuation multiple despite weaker earnings performance.

The valuation of common stock relative to operating profit exhibited significant volatility between 2017 and 2022, characterized by a sharp peak in market valuation followed by a period of compression and a subsequent rise driven by profit contraction.

Price to Operating Profit (P/OP) Dynamics

The P/OP ratio peaked in 2018 at 111.65, coinciding with the highest recorded share price of 394.46. A subsequent contraction occurred through 2020, where the ratio reached a minimum of 35.41. This decline was driven by a simultaneous decrease in share price and a steady increase in operating profit per share. From 2021 to 2022, the ratio trended upward again, ending at 76.33.

Operating Profitability Trends

Operating profit per share demonstrated consistent growth from 2017 (2.06) through 2020 (5.54). However, a reversal is observed in the final two years, with profit per share declining to 5.07 in 2021 and further dropping to 3.09 by March 31, 2022. This downturn in operational profitability contributed to the expansion of the P/OP multiple in the final period.

Share Price Correlation

Share price movements were non-linear, showing a dramatic increase in 2018 and subsequent fluctuations. The disconnect between the share price and operating profit is most evident in 2018, where the price increase far outpaced profit growth, and in 2022, where the P/OP ratio rose despite a lower share price relative to the 2018 peak, primarily due to the sharp decline in operating profit per share.

An analysis of the valuation metrics from 2017 to 2022 reveals a significant divergence between fundamental revenue growth and market valuation. While sales per share demonstrated a consistent upward trajectory throughout the period, the share price and the resulting Price-to-Sales (P/S) ratio exhibited substantial volatility, suggesting that market sentiment fluctuated independently of the underlying revenue growth.

Sales per Share Growth

A steady and linear increase in sales per share is observed, rising from 10.16 US$ in 2017 to 22.64 US$ in 2022. This represents a consistent expansion of the revenue base on a per-share basis over the six-year period.

Share Price Volatility

The share price experienced erratic movements, peaking at 394.46 US$ in 2018 before declining to a period low of 196.32 US$ in 2020. A partial recovery occurred in 2021, reaching 280.00 US$, followed by a moderate decline to 235.75 US$ by March 31, 2022.

Price-to-Sales (P/S) Ratio Trends

The P/S ratio shows extreme variance, reaching a peak of 29.55 in 2018, which indicates a period of aggressive market valuation relative to revenue. Following this peak, the ratio underwent a significant correction, falling to 10.50 in 2020. Despite a brief increase to 14.96 in 2021, the ratio contracted again to 10.41 by 2022.

Valuation Compression

A notable trend of valuation compression is evident toward the end of the period. By 2022, the P/S ratio reached its lowest point in the dataset (10.41) despite sales per share reaching their highest point (22.64 US$). This indicates that the market began assigning a lower multiple to each dollar of revenue compared to the valuations seen between 2017 and 2019.

The analysis of valuation ratios reveals a divergence between the growth of intrinsic book value and the market's valuation multiple from 2017 to 2022.

Book Value per Share (BVPS)

A consistent and uninterrupted upward trend is observed in the book value per share. The value increased annually, rising from 10.32 US$ on March 31, 2017, to 32.99 US$ by March 31, 2022. This indicates a steady accumulation of net assets attributable to common shareholders over the six-year period.

Share Price Performance

The market price of the common stock exhibited significant volatility. A substantial peak occurred on March 31, 2018, reaching 394.46 US$. Following this peak, the price experienced a general decline with intermittent fluctuations, ending the period at 235.75 US$ on March 31, 2022.

Price to Book Value (P/BV) Ratio

The P/BV ratio reached a maximum of 25.44 in 2018, reflecting a period of high market premium relative to the company's accounting value. Subsequently, a contraction in the multiple is evident, as the ratio declined to 7.15 by March 31, 2022. This downward trajectory in the P/BV ratio, occurring despite the steady increase in BVPS, suggests a compression in the valuation multiple the market was willing to pay for each dollar of book value.